FLEBOGAMMA Side Effects

6692396-5 | Abdominal Pain Upper, Alanine Aminotransferase Increased, Anti-hbc Antibody Positive, Anti-hbc Igg Antibody Positive, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Gastrointestinal Disorder, Hepatitis C Antibody Positive
on Mar 31, 2010 Female patient from SPAIN , 65 years of age, was diagnosed with blood immunoglobulin g decreased and was treated with Flebogamma (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, alanine aminotransferase increased, anti-hbc antibody positive, anti-hbc igg antibody positive, aspartate aminotransferase increased, blood alkaline phosphatase increased, gastrointestinal disorder, hepatitis c antibody positive. Flebogamma dosage: Iv, For Years.

6575174-7 | Chest Pain, Dizziness, Headache, Hypotension, Muscular Weakness, Nausea
Patient was taking Flebogamma (View Usage). Patient had the following side effects: chest pain (What is chest pain?), dizziness (What is dizziness?), headache (What is headache?), hypotension, muscular weakness, nausea (What is nausea?) on Jan 13, 2010 from PORTUGAL Additional patient health information: Female patient , 64 years of age, weighting 158.7 lb, was diagnosed with chronic inflammatory demyelinating polyradiculoneuropathy and. Flebogamma dosage: Intravenous.

6486520-7 | Headache, Hepatitis Cholestatic, Leukocytosis, Nausea, Pyrexia
Adverse event was reported on Sep 22, 2009 by a Male patient taking Flebogamma (View Usage) (Dosage: 50 G Iv) was diagnosed with multifocal motor neuropathy and. Location: IRELAND , 54 years of age, After Flebogamma was administered, patient had the following side effects: headache (What is headache?), hepatitis cholestatic, leukocytosis, nausea (What is nausea?), pyrexia. During the same period patient was treated with CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), AUGMENTIN (AMOXICILLIN CLAVULANIC ACID) (View Augmentin (amoxicillin-clavulanic Acid) Review and Augmentin (amoxicillin-clavulanic Acid) Label ). Patient was hospitalized.

6181880-9 | Angina Pectoris, Electrocardiogram St-t Segment Elevation
on Apr 02, 2009 Male patient from SPAIN , 80 years of age, was diagnosed with thrombocytopenic purpura and was treated with Flebogamma (View Usage). Patient experienced the following unwanted or unexpected effects: angina pectoris, electrocardiogram st-t segment elevation. Flebogamma dosage: 70 Gm. During the same period patient was treated with PREDNISONA 100 MG (View Prednisona 100 Mg Review and Prednisona 100 Mg Label ).


6151954-7 | Chronic Lymphocytic Leukaemia, Disease Recurrence, Hepatitis B
on Mar 25, 2009 Female patient from IRELAND , 65 years of age, was diagnosed with lymphocytic leukaemia and was treated with Flebogamma (View Usage). Patient had the following side effects: chronic lymphocytic leukaemia, disease recurrence, hepatitis b (What is hepatitis b?). Flebogamma dosage: 10g Iv. During the same period patient was treated with OCTAPLAS (A738C9501) (4 Units) (View Octaplas (a738c9501) Review and Octaplas (a738c9501) Label ). Patient was hospitalized.

6110728-3 | Hepatitis B
Patient was taking Flebogamma (View Usage). After Flebogamma was administered, patient had the following side effects: hepatitis b (What is hepatitis b?) on Feb 13, 2009 from IRELAND Additional patient health information: Female patient , 65 years of age, was diagnosed with lymphocytic leukaemia and. Flebogamma dosage: 10g Iv. During the same period patient was treated with OCTAPLAS (A738C9501) (4 Units Iv) (View Octaplas (a738c9501) Review and Octaplas (a738c9501) Label ). Patient was hospitalized.

6025517-8 | Administration Site Reaction, Bronchiectasis, Confusional State, Infusion Related Reaction, Mediastinal Disorder, Pneumonitis, Product Quality Issue, Respiratory Disorder
Adverse event was reported on Dec 11, 2008 by a Female patient taking Flebogamma (View Usage) (Dosage: 20 G (0.26g/kg) Iv First Dose) was diagnosed with hypogammaglobulinaemia and. Location: UNITED KINGDOM , 72 years of age, weighting 76.30 lb, Patient experienced the following unwanted or unexpected effects: administration site reaction, bronchiectasis, confusional state, infusion related reaction, mediastinal disorder, pneumonitis, product quality issue, respiratory disorder. During the same period patient was treated with ANTIBIOTICS IV (MEROPENEM, STANDARD DOSE) (View Antibiotics Iv (meropenem, Standard Dose) Review and Antibiotics Iv (meropenem, Standard Dose) Label ), STEROIDS O (PREDNISOLOEN, 40 MG) (View Steroids O (prednisoloen, 40 Mg) Review and Steroids O (prednisoloen, 40 Mg) Label ). Patient was hospitalized.

6020657-1 | Abasia, Amnesia, Back Pain, Confusional State, Cough, Depression, Diarrhoea, Dysarthria, Dysphonia
on Dec 24, 2008 Male patient from UNITED STATES , 59 years of age, weighting 250.0 lb, was diagnosed with chronic inflammatory demyelinating polyradiculoneuropathy and was treated with Flebogamma (View Usage). Patient had the following side effects: abasia, amnesia, back pain (What is back pain?), confusional state, cough, depression (What is depression?), diarrhoea, dysarthria, dysphonia. Flebogamma dosage: 60 Gram/day 28 Days.

6012701-2 | Alveolitis Allergic, Dyspnoea, Pyrexia
on Dec 05, 2008 Female patient from UNITED KINGDOM , 72 years of age, was diagnosed with hypogammaglobulinaemia and was treated with Flebogamma (View Usage). After Flebogamma was administered, patient had the following side effects: alveolitis allergic, dyspnoea, pyrexia. Flebogamma dosage: Iv. Patient was hospitalized.

5927452-X | Colitis, Enterocolitis Infectious, Hepatitis B, Hepatitis Infectious
Patient was taking Flebogamma (View Usage). Patient experienced the following unwanted or unexpected effects: colitis, enterocolitis infectious, hepatitis b (What is hepatitis b?), hepatitis infectious on Oct 21, 2008 from SPAIN Additional patient health information: Male patient , 35 years of age, was diagnosed with congenital hypogammaglobulinaemia and. Flebogamma dosage: 20 G (once A Month). During the same period patient was treated with GAMMAGARD LIQUID (View Gammagard Liquid Review and Gammagard Liquid Label ).

5878978-9 | Blood Pressure Increased, Chest Pain, Dyspnoea
Adverse event was reported on Sep 11, 2008 by a Female patient taking Flebogamma (View Usage) (Dosage: 60grams Iv X 1) was diagnosed with chronic lymphocytic leukaemia and. Location: UNITED STATES , 68 years of age, weighting 130.1 lb, Patient had the following side effects: blood pressure increased, chest pain (What is chest pain?), dyspnoea. During the same period patient was treated with BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ), CHRONULAR (View Chronular Review and Chronular Label ), MORPHINE (View Morphine Review and Morphine Label ), CORTEF (View Cortef Review and Cortef Label ), ZOVIRAX (View Zovirax Review and Zovirax Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), TESSALON (View Tessalon Review and Tessalon Label ).

5586900-8 | Back Pain, Dyskinesia, Infusion Related Reaction, Urticaria
on Jan 08, 2008 Female patient from UNITED STATES , 56 years of age, weighting 181.9 lb, was diagnosed with neuropathy peripheral and was treated with Flebogamma (View Usage). After Flebogamma was administered, patient had the following side effects: back pain (What is back pain?), dyskinesia, infusion related reaction, urticaria. Flebogamma dosage: 35gm Every 3 Weeks Iv Drip.

5548886-1 | Hepatitis C, Thrombocytopenia
on Nov 29, 2007 Female patient from SPAIN , 62 years of age, weighting 125.7 lb, was diagnosed with autoimmune thrombocytopenia and was treated with Flebogamma (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis c (What is hepatitis c?), thrombocytopenia. Flebogamma dosage: 400 Mg/kg/month, Iv; March - October 2007. During the same period patient was treated with DEFLAZACORT (GLUCOCORTICOID) (View Deflazacort (glucocorticoid) Review and Deflazacort (glucocorticoid) Label ).

5466550-4 | Meningitis Aseptic
Patient was taking Flebogamma (View Usage). Patient had the following side effects: meningitis aseptic on Sep 24, 2007 from UNITED STATES Additional patient health information: Female patient , 29 years of age, weighting 132.1 lb, was diagnosed with mononeuropathy multiplex and. Flebogamma dosage: 25 G/daily For 5 Days Iv. During the same period patient was treated with GAVOPANTIN (View Gavopantin Review and Gavopantin Label ), OXYCODON (View Oxycodon Review and Oxycodon Label ), PERCOCET (View Percocet Review and Percocet Label ). Patient was hospitalized.

5387614-X | Cerebral Infarction, Chest Pain, Ischaemic Stroke, Subdural Haematoma
Adverse event was reported on Jul 12, 2007 by a Male patient taking Flebogamma (View Usage) (Dosage: See Attached) was diagnosed with idiopathic thrombocytopenic purpura and. Location: UNITED STATES , weighting 180.8 lb, After Flebogamma was administered, patient had the following side effects: cerebral infarction, chest pain (What is chest pain?), ischaemic stroke, subdural haematoma. Patient was hospitalized and became disabled.

5374374-1 | Blister, Burning Sensation, Infusion Site Swelling, Injection Site Reaction
on Jun 28, 2007 Female patient from UNITED STATES , 69 years of age, weighting 260.0 lb, was diagnosed with immunodeficiency common variable and was treated with Flebogamma (View Usage). Patient experienced the following unwanted or unexpected effects: blister, burning sensation, infusion site swelling, injection site reaction. Flebogamma dosage: 42 Grams Monthly Iv Drip.

5095487-8 | Pulmonary Oedema
on Aug 31, 2006 Female patient from UNITED STATES , 29 years of age, was treated with Flebogamma (View Usage). Patient had the following side effects: pulmonary oedema. Flebogamma dosage: . Patient was hospitalized.

4996985-5 | Chest Pain, Heart Rate Increased, Infusion Related Reaction, Pulmonary Embolism, Respiratory Disorder, Respiratory Rate Increased
Patient was taking Flebogamma (View Usage). After Flebogamma was administered, patient had the following side effects: chest pain (What is chest pain?), heart rate increased, infusion related reaction, pulmonary embolism (What is pulmonary embolism?), respiratory disorder, respiratory rate increased on May 08, 2006 from UNITED STATES Additional patient health information: Male patient , 41 years of age, weighting 172.0 lb, was diagnosed with multifocal motor neuropathy and. Flebogamma dosage: 50 Gm Q Week Iv. Patient was hospitalized.

4847089-3 | Infusion Related Reaction, Paraesthesia Oral, Sensory Disturbance
Adverse event was reported on Dec 06, 2005 by a Female patient taking Flebogamma (View Usage) (Dosage: 1gm/kg/day X 2 Days Iv) was diagnosed with myasthenia gravis and. Location: UNITED STATES , weighting 136.0 lb, Patient experienced the following unwanted or unexpected effects: infusion related reaction, paraesthesia oral, sensory disturbance.

4809341-7 | Pericarditis, Pleurisy, Pneumonia
on Sep 30, 2005 Male patient from GERMANY , 57 years of age, weighting 176.4 lb, was diagnosed with peripheral motor neuropathy and was treated with Flebogamma (View Usage). Patient had the following side effects: pericarditis, pleurisy, pneumonia (What is pneumonia?). Flebogamma dosage: 120 G Every 6 Weeks Iv----for Years. During the same period patient was treated with ACETYL SALICYLIC ACID (PROPHYLAXIS) (View Acetyl Salicylic Acid (prophylaxis) Review and Acetyl Salicylic Acid (prophylaxis) Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), BISOPROLOL (HYPERTENSION) (View Bisoprolol (hypertension) Review and Bisoprolol (hypertension) Label ), PANTOPRAZOL (PROPHYLAXIS) (View Pantoprazol (prophylaxis) Review and Pantoprazol (prophylaxis) Label ). Patient was hospitalized.